![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1643, 2008-01, pp. : 6-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
T2DM treatment ADVANCE comes with caveats
Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Variable results for targeted insulin treatment in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmaceutical Programming, Vol. 4, Iss. 1-2, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Many patients with DM missing lipid targets, missing treatment
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 525, 2007-01 ,pp. :